The origins of cancer robustness and evolvability
Data up to Jan 2025
Total Citations Per Year
Abstract
References (169)
A genetic model for colorectal tumorigenesis
1990 • 11,800 citations
MicroRNA expression profiles classify human cancers
2005 • 9,457 citations
Crystal structure of the nucleosome core particle at 2.8 Å resolution
1997 • 8,906 citations
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 • 7,243 citations
Genetic Alterations during Colorectal-Tumor Development
1988 • 6,691 citations
The Clonal Evolution of Tumor Cell Populations
1976 • 6,310 citations
A microRNA expression signature of human solid tumors defines cancer gene targets
2006 • 5,638 citations
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
2008 • 5,528 citations
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 • 4,860 citations
Metabolic stability and epigenesis in randomly constructed genetic nets
1969 • 4,565 citations
Why do cancers have high aerobic glycolysis?
2004 • 4,534 citations
The Epigenomics of Cancer
2007 • 4,239 citations
Genetic instabilities in human cancers
1998 • 4,165 citations
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
2004 • 4,068 citations
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
2008 • 3,870 citations
MUTATIONS OF BACTERIA FROM VIRUS SENSITIVITY TO VIRUS RESISTANCE
1943 • 3,852 citations
EGFRMutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 • 3,807 citations
A microRNA polycistron as a potential human oncogene
2005 • 3,482 citations
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
2006 • 3,040 citations
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
2006 • 3,029 citations
Patterns of somatic mutation in human cancer genomes
2007 • 2,975 citations
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
1993 • 2,884 citations
Bacterial Persistence as a Phenotypic Switch
2004 • 2,806 citations
The Genomic Landscapes of Human Breast and Colorectal Cancers
2007 • 2,716 citations
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
1993 • 2,711 citations
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 • 2,394 citations
Epigenetics in cancer
2009 • 2,332 citations
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
1996 • 2,304 citations
Hsp90 as a capacitor for morphological evolution
1998 • 2,261 citations
Hypoxia in cancer: significance and impact on clinical outcome
2007 • 2,062 citations
Biological robustness
2004 • 2,025 citations
Adaptation from standing genetic variation
2007 • 1,951 citations
The epigenetic progenitor origin of human cancer
2005 • 1,839 citations
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
2005 • 1,838 citations
Efficient tumour formation by single human melanoma cells
2008 • 1,756 citations
Cancer as an evolutionary and ecological process
2006 • 1,658 citations
An operational definition of epigenetics: Figure 1.
2009 • 1,644 citations
Tumor heterogeneity: Causes and consequences
2009 • 1,509 citations
The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis
1954 • 1,475 citations
Degeneracy and complexity in biological systems
2001 • 1,393 citations
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
2003 • 1,360 citations
The age distribution of cancer and a multi-stage theory of carcinogenesis
2004 • 1,306 citations
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.
1999 • 1,252 citations
Immunity to Methylcholanthrene-Induced Sarcomas
1957 • 1,241 citations
Protein stability promotes evolvability
2006 • 1,161 citations
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
2010 • 1,118 citations
Two genetic hits (more or less) to cancer
2001 • 1,108 citations
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells
2008 • 1,095 citations
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
2009 • 1,060 citations
Evolvability
1998 • 1,051 citations
Robustness of Cellular Functions
2004 • 1,051 citations
Phenotypic plasticity and evolution by genetic assimilation
2006 • 1,000 citations
Developmental plasticity and the origin of species differences
2005 • 925 citations
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
2006 • 913 citations
Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies
2007 • 910 citations
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells
2007 • 819 citations
Complexity and robustness
2002 • 787 citations
Adaptive Therapy
2009 • 736 citations
Phase II Trial of Gefitinib in Recurrent Glioblastoma
2003 • 730 citations
MicroRNA-Mediated Feedback and Feedforward Loops Are Recurrent Network Motifs in Mammals
2007 • 722 citations
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
2008 • 699 citations
Homeostasis and Differentiation in Random Genetic Control Networks
1969 • 669 citations
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005 • 661 citations
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
2005 • 657 citations
PERSPECTIVE: EVOLUTION AND DETECTION OF GENETIC ROBUSTNESS
2003 • 637 citations
Robustness and evolvability: a paradox resolved
2007 • 632 citations
Phenotypic Consequences of Promoter-Mediated Transcriptional Noise
2006 • 627 citations
Co-evolution of tumor cells and their microenvironment
2008 • 602 citations
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
2008 • 591 citations
Smoothness within ruggedness: the role of neutrality in adaptation.
1996 • 562 citations
Mechanisms of Chromosomal Instability
2010 • 560 citations
Uncovering cryptic genetic variation
2004 • 548 citations
Species- and cell type-specific requirements for cellular transformation
2004 • 542 citations
Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspective
2009 • 541 citations
Feedback control of intercellular signalling in development
2000 • 535 citations
Errors in DNA replication as a basis of malignant changes.
1974 • 527 citations
Molecular chaperones and the stress of oncogenesis
2004 • 507 citations
Hereditary cancer: Two hits revisited
1996 • 497 citations
Inferring tumor progression from genomic heterogeneity
2009 • 493 citations
Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours
2009 • 492 citations
p53 Enters the MicroRNA World
2007 • 483 citations
Heat-shock proteins as regulators of apoptosis
2003 • 468 citations
How many mutations are required for tumorigenesis? implications from human cancer data
1993 • 466 citations
Tumor Hypoxia and Malignant Progression
2004 • 464 citations
Evolution of neoplastic cell lineages in Barrett oesophagus
1999 • 448 citations
Cancer as a robust system: implications for anticancer therapy
2004 • 447 citations
Heat-shock protein hsp90 governs the activity of pp60v-src kinase.
1993 • 420 citations
Epitope Landscape in Breast and Colorectal Cancer
2008 • 408 citations
A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
1996 • 407 citations
Mitotic chromosomal instability and cancer: mouse modelling of the human disease
2010 • 405 citations
Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?
2007 • 400 citations
Robustness Can Evolve Gradually in Complex Regulatory Gene Networks with Varying Topology
2007 • 394 citations
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma
2007 • 385 citations
Chaperonin overexpression promotes genetic variation and enzyme evolution
2009 • 352 citations
Mutational robustness can facilitate adaptation
2010 • 342 citations
MicroRNAs and cancer: An overview
2008 • 339 citations
Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice
2007 • 337 citations
Microenvironmental regulation of cancer development
2008 • 323 citations
Highly Optimized Tolerance: Robustness and Design in Complex Systems
2000 • 323 citations
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers
2008 • 304 citations
Distributed robustness versus redundancy as causes of mutational robustness
2005 • 292 citations
The tumor microenvironment and metastatic disease
2008 • 291 citations
Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.
1986 • 275 citations
Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal
2010 • 271 citations
Chromosomal instability determines taxane response
2009 • 270 citations
Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species
2003 • 267 citations
Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage
2006 • 267 citations
Hidden Reaction Norms, Cryptic Genetic Variation, and Evolvability
2008 • 247 citations
Modern biomedical research: an internally self-consistent universe with little contact with medical reality?
2003 • 243 citations
Mutational Heterogeneity in Human Cancers: Origin and Consequences
2009 • 239 citations
A C. elegans genome-scale microRNA network contains composite feedback motifs with high flux capacity
2008 • 236 citations
Doxorubicin gradients in human breast cancer.
1999 • 210 citations
Phenotypic heterogeneity and cellular origins of T cell malignancies
1981 • 200 citations
Mechanisms of Disease: cancer stem cells—targeting the evil twin
2008 • 194 citations
Degeneracy: A design principle for achieving robustness and evolvability
2009 • 194 citations
Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis
2000 • 191 citations
Sloppiness, robustness, and evolvability in systems biology
2008 • 190 citations
Karyotypic evolution in human malignant melanoma
1986 • 189 citations
Regulation of DNA repair in hypoxic cancer cells
2007 • 183 citations
Epistasis correlates to genomic complexity
2006 • 180 citations
Survival comparison between glioblastoma multiforme and other incurable cancers
2010 • 174 citations
Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
2009 • 172 citations
Receptor Tyrosine Kinase Coactivation Networks in Cancer
2010 • 162 citations
Degeneracy: a link between evolvability, robustness and complexity in biological systems
2010 • 161 citations
Epigenetic drivers and genetic passengers on the road to cancer
2008 • 159 citations
Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma
2001 • 136 citations
Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy.
1986 • 134 citations
Cancer stem cells: Back to Darwin?
2010 • 132 citations
Mutator pathways unleashed by epigenetic silencing in human cancer
2007 • 130 citations
Evolution of Resistance to Targeted Anti-Cancer Therapies during Continuous and Pulsed Administration Strategies
2009 • 123 citations
A stochastic model for the origin and treatment of tumors containing drug-resistant cells
1986 • 122 citations
Primitive, Quiescent and Difficult to Kill: The Role of Non-Proliferating Stem Cells in Chronic Myeloid Leukemia
2006 • 121 citations
Chromosomal instability: A composite phenotype that influences sensitivity to chemotherapy
2009 • 109 citations
Evolutionary dynamics of escape from biomedical intervention
2003 • 105 citations
The evolutionary origin of genetic instability in cancer development
2004 • 101 citations
Robustness promotes evolvability of thermotolerance in an RNA virus
2008 • 101 citations
Retreatment of Lung Adenocarcinoma Patients With Gefitinib Who Had Experienced Favorable Results From Their Initial Treatment With This Selective Epidermal Growth Factor Receptor Inhibitor: A Report of Three Cases
2005 • 94 citations
Efficiency of carcinogenesis with and without a mutator mutation
2006 • 92 citations
Genome based cell population heterogeneity promotes tumorigenicity: The evolutionary mechanism of cancer
2008 • 87 citations
Optimization of DNA polymerase mutation rates during bacterial evolution
2009 • 86 citations
A theoretical quantitative model for evolution of cancer chemotherapy resistance
2010 • 80 citations
Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas
2005 • 80 citations
RBP2‐H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells
2007 • 78 citations
Retreatment of patients with the same chemotherapy: Implications for clinical mechanisms of drug resistance
2001 • 77 citations
Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment
2003 • 75 citations
MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?
2009 • 73 citations
Cancer models, genomic instability and somatic cellular Darwinian evolution
2010 • 70 citations
Optimal control for a stochastic model of cancer chemotherapy
2000 • 70 citations
Glutathione and Gts1p drive beneficial variability in the cadmium resistances of individual yeast cells
2007 • 64 citations
On the karyotypic origin and evolution of cancer cells
2009 • 60 citations
Current trends in mathematical modeling of tumor–microenvironment interactions: a survey of tools and applications
2010 • 58 citations
Scale-free flow of life: on the biology, economics, and physics of the cell
2009 • 57 citations
Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro.
1997 • 55 citations
The age distribution of cancer and a multi-stage theory of carcinogenosis
2004 • 55 citations
Networked buffering: a basic mechanism for distributed robustness in complex adaptive systems
2010 • 51 citations
Oncogenic Mutations Reduce the Stability of Src Kinase
2004 • 51 citations
Epigenetics and cancer without genomic instability
2009 • 46 citations
Re-Expression of the Retinoblastoma-Binding Protein 2-Homolog 1 Reveals Tumor-Suppressive Functions in Highly Metastatic Melanoma Cells
2006 • 44 citations
Synonymous Genes Explore Different Evolutionary Landscapes
2008 • 38 citations
Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma
2004 • 38 citations
Cancer stem cells: A guide for skeptics
2009 • 36 citations
Modeling therapy resistance in genetically engineered mouse cancer models
2008 • 33 citations
Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer.
1999 • 33 citations
Mutator Mutations Enhance Tumorigenic Efficiency across Fitness Landscapes
2009 • 33 citations
Evolutionary dynamics and highly optimized tolerance
2005 • 31 citations
How evolution guides complexity
2009 • 26 citations
Clonal Selection in Malignant Transformation of Human Fibroblasts Transduced with Defined Cellular Oncogenes
2008 • 21 citations
The stability of various adaptations of Bact. lactis aerogenes (Aerobacter aerogenes)
1954 • 12 citations
Familial cutaneous melanoma and two-mutational-event modeling
1993 • 8 citations
Cited By (0)
No citing papers found in database